Cardiovascular and Obstetric Delivery Complications in Pregnant Women With Valvular Heart Disease

被引:7
作者
Minhas, Anum S. [1 ,2 ,6 ]
Rahman, Faisal [1 ,6 ]
Gavin, Nicole [3 ,6 ]
Cedars, Ari [1 ,6 ]
Vaught, Arthur Jason [3 ,6 ]
Zakaria, Sammy [1 ,6 ]
Resar, Jon [1 ,6 ]
Schena, Stefano [4 ,6 ]
Schulman, Steven [1 ,6 ]
Zhao, Di [5 ,6 ]
Hays, Allison G. [1 ,6 ]
Michos, Erin D. [1 ,6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Maternal Fetal Med, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ, Div Cardiac Surg, Sch Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Sch Med, Baltimore, MD USA
[6] Johns Hopkins Univ, Baltimore, MD USA
关键词
LOW-DOSE ASPIRIN; OUTCOMES;
D O I
10.1016/j.amjcard.2021.07.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Women with valvular heart disease may be more likely to have adverse obstetric and cardiovascular complications during pregnancy. Most current recommendations focus on stenotic lesions with less guidance regarding regurgitant lesions. We aimed to compare adverse events at delivery for women with various stenotic and regurgitant valvular diseases. We used the 2016 to 2018 National Inpatient Sample data to compare demographics, comorbidities, and obstetric and cardiovascular complications during delivery hospitalizations. After adjusting for clinical and socioeconomic factors, logistic regression was performed to investigate associations between valvular disease and outcomes. Among > 11.2 million deliveries, 20,349 were in women with valvular disease. Women with valvular disease were older, had longer length of stays, and higher costs associated with delivery. They had higher prevalence of underlying cardiovascular comorbidities compared with women without valvular disease (hypertension: 5.1 vs 0.25%; pulmonary hypertension: 7.0 vs < 0.1%). At delivery, they had higher adjusted odds of obstetric events including preeclampsia and/or eclampsia (aOR 1.9 [1.8 to 2.2]) and intrapartum/postpartum hemorrhage (aOR 1.4 [1.2 to 1.6]), and cardiovascular events including peripartum cardiomyopathy (aOR 65 [53 to 78]), pulmonary edema (aOR 17 [13 to 22]), acute ischemic heart disease (aOR 19 [12 to 30]) and arrhythmias (aOR 22 [19 to 27]). There were valve lesion-specific differences in the magnitude of risk but both stenotic and regurgitant lesions were associated with elevated risk of cardiovascular complications. In conclusion, pregnant women with stenotic and regurgitant valvular disease have a greater burden of cardiovascular comorbidities and increased odds of obstetric and cardiovascular events at delivery. These women may benefit from specialized care from a Cardio-Obstetrics team. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 50 条
  • [1] Risk Prediction of Cardiovascular Complications in Pregnant Women With Heart Disease
    Martins, Luciana Carvalho
    Vilas Freire, Claudia Maria
    Braganca Capurucu, Carolina Andrade
    Pereira Nunes, Maria do Carmo
    de Lima Rezende, Cezar Alencar
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2016, 106 (04) : 289 - 296
  • [2] Maternal Comorbidities and Complications of Delivery in Pregnant Women With Congenital Heart Disease
    Schlichting, Lauren E.
    Insaf, Tabassum Z.
    Zaidi, Ali N.
    Lui, George K.
    Van Zutphen, Alissa R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (17) : 2181 - 2191
  • [3] Predictors of obstetric complications in women with heart disease
    Goya, Maria
    Casellas, Manel
    Merced, Carme
    Pijuan-Domenech, Antonia
    Galian, Laura
    Dos, Laura
    Casaldaliga, Jaume
    Subirana, Mayte
    Pedrosa, Valle
    Rojas, Mireia
    Martinez, Cristina
    Ferreira, Ignacio
    Monts, Montserrat
    Gascon, Andrea
    Mendoza, Manel
    Baro, Francesc
    Suy, Anna
    Lopez-Gil, Victoria
    Manrique, Susana
    Tornos, Pilar
    Garcia-Dorado, David
    Carreras, Elena
    Cabero, Luis
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (14) : 2306 - 2311
  • [4] Valvular Procedures in Pregnant Women With Congenital Heart Disease: The Magee Obstetric Maternal and Infant (MOMI) ACHD Substudy
    Saraf, Anita
    Hindes, Morgan
    Berlacher, Kathryn
    Hoskoppal, Arvind
    Catov, Janet M.
    Kalogeropoulos, Andreas P.
    Pastena, Paola
    CIRCULATION, 2023, 148
  • [5] Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease
    Baghel, Jyoti
    Keepanasseril, Anish
    Pillai, Ajith Ananthakrishna
    Mondal, Nivedita
    Jeganathan, Yavanasuriya
    Kundra, Pankaj
    HEART, 2020, 106 (18) : 1400 - +
  • [6] Cardiovascular Imaging During Pregnancy in Women with Congenital and Valvular Heart Disease
    Planek, Maria Isabel Camara
    Li, Shannon
    Herbst, Leyla
    Sutter, Joanne
    Sanghani, Rupa M.
    Volgman, Annabelle Santos
    Chen, Stuart H.
    CURRENT CARDIOVASCULAR IMAGING REPORTS, 2023, 16 (09) : 71 - 82
  • [7] Validation of Risk Stratification for Cardiac Events in Pregnant Women With Valvular Heart Disease
    Pande, Swaraj Nandini
    Suriya, J. Yavana
    Ganapathy, Sachit
    Pillai, Ajith Ananthakrishna
    Satheesh, Santhosh
    Mondal, Nivedita
    Kumar, K. T. Harichandra
    Silversides, Candice
    Siu, Samuel C.
    D'Souza, Rohan
    Keepanasseril, Anish
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (14) : 1395 - 1406
  • [8] Incidence and predictors of obstetric and fetal complications in women with structural heart disease
    van Hagen, Iris M.
    Roos-Hesselink, Jolien W.
    Donvito, Valentina
    Liptai, Csilla
    Morissens, Marielle
    Murphy, Daniel J.
    Galian, Laura
    Bazargani, Nooshin Mohd
    Cornette, Jerome
    Hall, Roger
    Johnson, Mark R.
    HEART, 2017, 103 (20) : 1610 - 1618
  • [9] Management of valvular heart disease in the pregnant patient
    Hutt, Erika
    Desai, Milind Y.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (08) : 495 - 501
  • [10] Valvular Heart Disease and Heart Failure in Women
    Crousillat, Daniela R.
    Wood, Malissa J.
    HEART FAILURE CLINICS, 2019, 15 (01) : 77 - +